The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Links

 

Gene Review

FRAT2  -  frequently rearranged in advanced T-cell...

Homo sapiens

Synonyms: FRAT-2, Frequently rearranged in advanced T-cell lymphomas 2, GSK-3-binding protein FRAT2
 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of FRAT2

 

High impact information on FRAT2

  • Further, in vitro assays using recombinant proteins directly demonstrated that FRAT-2 enhances GSK3 beta-mediated phosphorylation of a primed substrate to a greater extent than an unprimed substrate [3].
  • Characterization and tissue-specific expression of human GSK-3-binding proteins FRAT1 and FRAT2 [4].
  • We have isolated the entire coding sequence of human FRAT2 (frequently rearranged in advanced T-cell lymphomas-2) [4].
  • The FRAT2 gene was mapped to human chromosome 10q24 [2].
  • Thus, up-regulation of FRAT2 in human cancer might be implicated in carcinogenesis through activation of the WNT signaling pathway [2].
 

Biological context of FRAT2

 

Associations of FRAT2 with chemical compounds

  • FRAT2 and FRAT1 were more homologous in the acidic domain (96% identity), the proline-rich domain (92% identity), and the GSK-3beta binding domain (100% identity) [2].
 

Enzymatic interactions of FRAT2

 

Analytical, diagnostic and therapeutic context of FRAT2

References

  1. Molecular cloning and expression of proto-oncogene FRAT1 in human cancer. Saitoh, T., Mine, T., Katoh, M. Int. J. Oncol. (2002) [Pubmed]
  2. Molecular cloning and characterization of FRAT2, encoding a positive regulator of the WNT signaling pathway. Saitoh, T., Moriwaki, J., Koike, J., Takagi, A., Miwa, T., Shiokawa, K., Katoh, M. Biochem. Biophys. Res. Commun. (2001) [Pubmed]
  3. FRAT-2 preferentially increases glycogen synthase kinase 3 beta-mediated phosphorylation of primed sites, which results in enhanced tau phosphorylation. Stoothoff, W.H., Cho, J.H., McDonald, R.P., Johnson, G.V. J. Biol. Chem. (2005) [Pubmed]
  4. Characterization and tissue-specific expression of human GSK-3-binding proteins FRAT1 and FRAT2. Freemantle, S.J., Portland, H.B., Ewings, K., Dmitrovsky, F., DiPetrillo, K., Spinella, M.J., Dmitrovsky, E. Gene (2002) [Pubmed]
  5. FRAT1 and FRAT2, clustered in human chromosome 10q24.1 region, are up-regulated in gastric cancer. Saitoh, T., Katoh, M. Int. J. Oncol. (2001) [Pubmed]
 
WikiGenes - Universities